Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »
Reset 

PharmaForce International: Research Indicates Continued Migration Toward Specialty Oncology Sales Forces and Novel Breakthrough Medical Therapy Options for Cancer Patients

READING, Pa., Feb. 13, 2018 /PRNewswire/ -- Research published by PharmaForce International (PFI) shows 31% of pharmaceutical and biotech companies are deploying multiple oncology sales force sleeves that support an individual product. This strategic approach is employed in an effort to capitalize... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

WellDyneRx Launches Revitalized Website, Rebrand to Better Serve Clients and Members

LAKELAND, Fla., Feb. 13, 2018 /PRNewswire/ -- WellDyneRx, a full-service, independent Pharmacy Benefit Manager (PBM), launched a new website this week to better serve, educate and engage its clients and members, while more clearly communicating its mission and place in the market for those in... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Phase II trial demonstrates activity of durvalumab in patients with recurrent or metastatic head and neck cancer

SCOTTSDALE, Ariz., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Analysis of the phase II CONDOR trial indicates that the immune checkpoint inhibitor durvalumab is tolerable among heavily pre-treated patients with recurrent or metastatic head and neck cancer and has the potential to slow growth in... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Nivolumab immunotherapy safe and feasible during chemoradiation for advanced head and neck cancer

SCOTTSDALE, Ariz., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Cabozantinib shows significant activity in the first line for differentiated thyroid cancer

SCOTTSDALE, Ariz., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Results of a new phase II clinical trial indicate that cabozantinib offers an active therapy option for patients with differentiated thyroid cancer (DTC) that has progressed following surgery and treatment with radioactive iodine (RAI).... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Spherix Global Insights Announces Collaboration with Oncology Industry Experts to Expand Portfolio of Independent Reports Covering Highly Dynamic Markets

EXTON, Pa., Feb. 13, 2018 /PRNewswire/ -- Spherix Global Insights is a recognized market intelligence agency providing independent coverage of the autoimmune, multiple sclerosis, and nephrology markets. Unlike other firms offering syndicated reports, Spherix derives actionable insights from... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Lower-dose radiation therapy effective and safe for HPV-related head and neck cancer after induction chemotherapy, trial finds

SCOTTSDALE, Ariz., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papillomavirus (HPV), including those with advanced nodal disease, can receive substantially lower radiation doses... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

DKT International and Shanghai Dahua Pharmaceutical Partner To Increase Access to Contraceptive Implants

WASHINGTON, Feb. 13, 2018 /PRNewswire/ -- DKT International, one of the world's largest providers of family planning services, is proud to announce an agreement with Shanghai Dahua Pharmaceutical Co., Ltd. to serve as the global marketing partner for Levoplant, a WHO-Prequalified contraceptive... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Roche receives FDA clearance for Factor II and Factor V test on the cobas® 4800 system

PLEASANTON, Calif., Feb. 13, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA clearance for the cobas® Factor II and Factor V Test for use on the cobas® 4800 system. The test enables laboratories to simultaneously assess Factor... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

RoxSan Pharmacy Notifies Patients of Potential Breach of Unsecured Personal Information

SANTA MONICA, Calif., Feb. 13, 2018 /PRNewswire/ -- As part of its commitment to patient privacy, RoxSan Pharmacy ("RoxSan") notified 1,049 patients of a potential breach of unsecured personal patient protected health information. RoxSan is notifying affected individuals in as timely a manner... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

CRISPR - Fast Initial Growth, But Long-Term Revenues Will Depend on "Wins"

ROCKVILLE, Md., Feb. 13, 2018 /PRNewswire/ -- New York City-based market research firm Kalorama Information projects fast revenue growth for the most important gene editing technology CRISPR/Cas9 - 33.7% growth over the next five years, as revenues grow from $779 million in 2017 to $5.2 billion... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Rapid Novor Inc Announces Residency in JLABS @ Toronto

KITCHENER, Ontario, Feb. 13, 2018 /PRNewswire-iReach/ -- Rapid Novor Inc, the world's leader in antibody protein sequencing using mass spectrometry, today announces that it becomes a resident company in Johnson & Johnson Innovation, JLABS @ Toronto, located in the MaRS Centre in Toronto,... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
Related companies:  Bertrand-Johnson Acoustics Inc | Johnson Global Medical Products Inc. | Rapid Novor Inc

Medical Marijuana, Inc. Subsidiary HempMeds® Supports U.S. Military Veterans with Exclusive Product Discounts

SAN DIEGO, Feb. 13, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Fidaxomicin Market 2025 Global Forecasts: Focus on Worldwide Industry

PUNE, India, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Accelerated Cure Project Launches Collaborative Research Program with Regeneron Genetics Center to Sequence DNA of Multiple Sclerosis Patients

WALTHAM, Mass., Feb. 13, 2018 /PRNewswire-USNewswire/ -- The Accelerated Cure Project for Multiple Sclerosis (ACP) announced a collaboration with the Regeneron Genetics Center (RGC), a wholly-owned subsidiary of Regeneron Pharmaceuticals, Inc., that will sequence the entire exome region of all... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018

Consumer Spending on Legal Cannabis Products Continues to Grow

NEW YORK, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Global Thyroid Gland Disorder Treatment Market: Increasing Incidence of Autoimmune Diseases Raise Thyroid Disorder Fears Globally, Says TMR

ALBANY, New York, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Global Bariatric Surgery Devices Market Forecast 2018-2028 - Visiongain Report

LONDON, February 13, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Groundbreaking Global Solution to Cure Cancer Sets New Goal

SEATTLE, Feb. 13, 2018 /PRNewswire/ -- If you or anyone that you care about has cancer, pay attention.

Read more ››
By: PR Newswire Association LLC. - 13 Feb 2018

Amplion Clinical Communications Strengthens C-Suite To Ready For Additional Growth Opportunities

NASHVILLE, Tenn., Feb. 13, 2018 /PRNewswire/ -- Amplion Clinical Communications, a healthcare technology company that's transforming the nurse call market into one that delivers data which helps hospitals achieve value-based... Read more ››

By: PR Newswire Association LLC. - 13 Feb 2018
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »
to the top ↑